Cite
APA Citation
von Tresckow, B., Fanale, M., Ardeshna, K. M., Chen, R., Meissner, J., Morschhauser, F., Moskowitz, C., Zinzani, P. L., Giezek, H., Balakumaran, A., Vo, T. T., Raut, M., & Brice, P. (2019). patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leukemia & lymphoma, 60(11), 2705–2711. http://access.bl.uk/ark:/81055/vdc_100094630675.0x00003f